145 related articles for article (PubMed ID: 9797777)
1. Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia.
Kobzev Y; Domracheva E; Zakharova A; Khoroshko N; Turkina A; Dewald G
Cancer Genet Cytogenet; 1998 Oct; 106(2):128-34. PubMed ID: 9797777
[TBL] [Abstract][Full Text] [Related]
2. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
[TBL] [Abstract][Full Text] [Related]
3. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
Song YQ; Li W; Kong LH; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287
[TBL] [Abstract][Full Text] [Related]
4. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
Schoch C; Schnittger S; Bursch S; Gerstner D; Hochhaus A; Berger U; Hehlmann R; Hiddemann W; Haferlach T
Leukemia; 2002 Jan; 16(1):53-9. PubMed ID: 11840263
[TBL] [Abstract][Full Text] [Related]
5. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals.
Mohr B; Bornhäuser M; Platzbecker U; Freiberg-Richter J; Naumann R; Prange-Krex G; Mohm J; Kroschinsky F; Ehninger G; Thiede C
Cancer Genet Cytogenet; 2001 Jun; 127(2):111-7. PubMed ID: 11425449
[TBL] [Abstract][Full Text] [Related]
6. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
Itoh T; Tamura S; Takemoto Y; Kakishita E
Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
[TBL] [Abstract][Full Text] [Related]
7. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
Martinet D; Mühlematter D; Jotterand Bellomo M
Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
[TBL] [Abstract][Full Text] [Related]
8. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.
Buño I; Wyatt WA; Zinsmeister AR; Dietz-Band J; Silver RT; Dewald GW
Blood; 1998 Oct; 92(7):2315-21. PubMed ID: 9746769
[TBL] [Abstract][Full Text] [Related]
9. Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-alpha therapy.
Tchirkov A; Giollant M; Tavernier F; Briançon G; Tournilhac O; Kwiatkowski F; Philippe P; Choufi B; Deméocq F; Travade P; Malet P
Br J Haematol; 1998 Jun; 101(3):552-7. PubMed ID: 9633901
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
11. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
12. Philadelphia chromosome in chronic myelogenous leukemia: confirmation of cytogenetic diagnosis in Ph positive and negative cases by fluorescence in situ hybridization.
Acar H; Stewart J; Connor MJ
Cancer Genet Cytogenet; 1997 Apr; 94(2):75-8. PubMed ID: 9109930
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
[TBL] [Abstract][Full Text] [Related]
14. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
[TBL] [Abstract][Full Text] [Related]
15. FISH analysis for CML monitoring?
Froncillo MC; Maffei L; Cantonetti M; Del Poeta G; Lentini R; Bruno A; Masi M; Tribalto M; Amadori S
Ann Hematol; 1996 Sep; 73(3):113-9. PubMed ID: 8841098
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis.
Cuneo A; Bigoni R; Emmanuel B; Smit E; Rigolin GM; Roberti MG; Bardi A; Piva N; Scapoli G; Castoldi G; Van Den Berghe H; Hagemeijer A
Leukemia; 1998 Nov; 12(11):1718-23. PubMed ID: 9823946
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
Jha CB; Kucheria K; Choudhary VP
Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
[TBL] [Abstract][Full Text] [Related]
19. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
20. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia.
Dewald GW; Wyatt WA; Juneau AL; Carlson RO; Zinsmeister AR; Jalal SM; Spurbeck JL; Silver RT
Blood; 1998 May; 91(9):3357-65. PubMed ID: 9558393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
